Document Detail


Red clover and soy isoflavones-an in vitro safety assessment.
MedLine Citation:
PMID:  21801124     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
Isoflavones from red clover and soy plant extracts are used in highly concentrated food supplements as an alternative to hormone replacement therapy. Due to their estrogenic activity, isoflavones are a focus of safety concerns about their potential to promote the growth of hormone-dependent cancer cells. In this study, isoflavones and plant extracts were tested for their effect on cell proliferation, apoptosis induction and cell cycle arrest. Isoflavones and plant extracts were applied in proliferation assays on 11 human cancer cell lines (representing cancers of the colon, prostate, breast, cervix, liver, pancreas, stomach and ovaries) and a fibroblast line to detect cytotoxic activity. Fluorescence-activated cell sorting was used to detect the induction of apoptosis or cell cycle arrest. Isoflavones and plant extracts significantly reduced the proliferation activity of the treated cancer cell lines. Growth promotion was not observed, but apoptosis or necrosis induction was, as was cell cycle arrest, with genistein as the most potent isoflavone. Isoflavones and plant extracts from soy and red clover, respectively, do not promote the growth of human cancer cells but induce decreased cell proliferation, increased apoptosis and cell cycle arrest. These results indicate that isoflavones can be considered safe compounds.
Authors:
Evelyne Reiter; Petra Gerster; Alois Jungbauer
Related Documents :
22024284 - Egf promotes the shedding of soluble e-cadherin in an adam10-dependent manner in prosta...
21669984 - Germ cell intercellular bridges.
22174914 - Generation of stratified squamous epithelial progenitor cells from mouse induced plurip...
22356764 - Interaction of hmc1q with leech microglial cells: involvement of c1qbp-related molecule...
7662964 - Classification of fanconi anemia patients by complementation analysis: evidence for a f...
21528324 - Cisplatin-induced cell death in human glioma.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2011-8-1
Journal Detail:
Title:  Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology     Volume:  -     ISSN:  1473-0766     ISO Abbreviation:  -     Publication Date:  2011 Aug 
Date Detail:
Created Date:  2011-8-1     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8807913     Medline TA:  Gynecol Endocrinol     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Affiliation:
Department of Biotechnology, University of Natural Resources and Life Sciences Vienna , Vienna , Austria.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Fatty acid composition of mid-trimester amniotic fluid in women of different ethnicities.
Next Document:  Effect of exercise training on the cardiovascular and biochemical parameters in women with eNOS gene...